| Metric | შპს Linema Pharm | შპს თეგა ფარმა | შპს ნ-ფარმა |
|---|---|---|---|
| Growth | |||
| Revenue | ₾3.9m₾2.1m | ₾3.9m₾5.3m | ₾1.2m₾2.5m |
| Revenue growth | 88.1% | -26.7% | -53.5% |
| Profitability | |||
| EBITDA | ₾1.6m₾584k | ₾41k₾194k | ₾309k₾479k |
| EBITDA margin | 40.5%28.0% | 1.1%3.6% | 26.4%19.1% |
| Net profit | ₾1.5m₾581k | ₾16k₾140k | |
| ₾308k₾479k |
| Net margin | 38.9%27.9% | 0.4%2.6% | 26.3%19.1% |
| Balance sheet | |||
| Total assets | ₾6.3m₾4.9m | ₾597k₾1.4m | ₾1.5m₾1.4m |
| Total equity | ₾5.6m₾4.3m | ₾550k₾628k | ₾1.2m₾851k |
| ROE | 27.1%13.6% | 2.9%22.3% | 26.6%56.3% |